Sense of control, selective attention, cognitive inhibition, and psychosocial outcomes after Retraining and Control Therapy (ReACT) in pediatric functional seizures

[1]  W. LaFrance,et al.  Treatment of Psychogenic Nonepileptic Seizures , 2022, Current Neurology and Neuroscience Reports.

[2]  J. Szaflarski,et al.  Psychiatric and personality factors in pediatric functional seizures: A prospective case-control study , 2022, Seizure.

[3]  J. Szaflarski,et al.  Sense of control, selective attention and cognitive inhibition in pediatric functional seizures: A prospective case-control study , 2022, Seizure.

[4]  A. Fobian,et al.  Treatment Approaches for Functional Neurological Disorders in Children , 2022, Current Treatment Options in Neurology.

[5]  A. Fobian,et al.  Somatic Symptoms in Adolescents With an Ill Parent , 2022, Psychosomatic medicine.

[6]  J. Szaflarski,et al.  Regional brain atrophy and aberrant cortical folding relate to anxiety and depression in patients with traumatic brain injury and psychogenic nonepileptic seizures , 2021, Epilepsia.

[7]  J. Szaflarski,et al.  One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures , 2021, Epilepsy & Behavior Reports.

[8]  J. Szaflarski,et al.  Neuroinflammation as a pathophysiological factor in the development and maintenance of functional seizures: A hypothesis , 2021, Epilepsy & behavior reports.

[9]  J. Szaflarski,et al.  Retraining and Control Therapy (ReACT) is a bottom-up, body-oriented intervention , 2021, Seizure.

[10]  J. Szaflarski,et al.  Identifying and evaluating novel treatment targets for the development of evidence-based interventions for functional neurological disorder , 2021, Epilepsy & behavior reports.

[11]  A. Fobian,et al.  Changing the culture of care for children and adolescents with functional neurological disorder , 2021, Epilepsy & behavior reports.

[12]  R. Nielsen,et al.  Psychiatric Disorders in Children and Adolescents With Psychogenic Nonepileptic Seizures , 2021, Neurology.

[13]  K. Weiss,et al.  Functional Neurological Symptom Disorder in Children and Adolescents within Medical Settings , 2020, Journal of Clinical Psychology in Medical Settings.

[14]  J. Szaflarski,et al.  Retraining and control therapy for pediatric psychogenic non‐epileptic seizures , 2020, Annals of clinical and translational neurology.

[15]  Mark Johnson,et al.  Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial , 2020, The lancet. Psychiatry.

[16]  D. Perez.  The CODES trial for dissociative seizures: a landmark study and inflection point. , 2020, The lancet. Psychiatry.

[17]  A. Fobian,et al.  A Systematic Review of Somatic Symptoms in Children With a Chronically Ill Family Member , 2020, Psychosomatic medicine.

[18]  A. Fobian,et al.  A review of functional neurological symptom disorder etiology and the integrated etiological summary model. , 2019, Journal of psychiatry & neuroscience : JPN.

[19]  M. Hallett,et al.  Impaired sense of agency in functional movement disorders: An fMRI study , 2017, PloS one.

[20]  V. R. Weersing,et al.  Evidence Base Update of Psychosocial Treatments for Child and Adolescent Depression , 2017, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[21]  M. Hallett,et al.  Impaired self-agency in functional movement disorders , 2016, Neurology.

[22]  M. Vidailhet,et al.  Illusion of agency in patients with Gilles de la Tourette Syndrome , 2016, Cortex.

[23]  P. Siddarth,et al.  A multisite controlled study of risk factors in pediatric psychogenic nonepileptic seizures , 2014, Epilepsia.

[24]  J. Szaflarski,et al.  Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. , 2014, JAMA psychiatry.

[25]  C. Reilly,et al.  Psychogenic nonepileptic seizures in children: A review , 2013, Epilepsia.

[26]  M. Hallett,et al.  Action‐effect binding is decreased in motor conversion disorder: Implications for sense of agency , 2013, Movement disorders : official journal of the Movement Disorder Society.

[27]  M. Edwards,et al.  Attention to self in psychogenic tremor , 2011, Movement disorders : official journal of the Movement Disorder Society.

[28]  Janet Metcalfe,et al.  Dissociating Neural Correlates of Action Monitoring and Metacognition of Agency , 2011, Journal of Cognitive Neuroscience.

[29]  M. Hallett,et al.  Aberrant supplementary motor complex and limbic activity during motor preparation in motor conversion disorder , 2011, Movement disorders : official journal of the Movement Disorder Society.

[30]  G. Keitner,et al.  Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures , 2010, Neurology.

[31]  Janet Metcalfe,et al.  Metacognition of agency across the lifespan , 2010, Cognition.

[32]  P. Siddarth,et al.  Pediatric psychogenic nonepileptic seizures: A study of assessment tools , 2010, Epilepsy & Behavior.

[33]  M. Hallett,et al.  The involuntary nature of conversion disorder , 2010, Neurology.

[34]  L. Williams,et al.  Self-protective organization in children with conversion and somatoform disorders. , 2009, Journal of psychosomatic research.

[35]  P. Fink,et al.  Functional somatic symptoms and associated impairment in 5–7-year-old children: the Copenhagen Child Cohort 2000 , 2009, European Journal of Epidemiology.

[36]  M. Desmurget,et al.  Movement Intention After Parietal Cortex Stimulation in Humans , 2009, Science.

[37]  J. Garber,et al.  Children's Somatization Inventory: psychometric properties of the revised form (CSI-24). , 2009, Journal of pediatric psychology.

[38]  P. Haggard,et al.  Who is causing what? The sense of agency is relational and efferent-triggered , 2008, Cognition.

[39]  J. Metcalfe,et al.  Effects of intranasal methamphetamine on metacognition of agency , 2008, Psychopharmacology.

[40]  Kette D. Valente,et al.  Psychogenic nonepileptic seizures in children and adolescents with epilepsy , 2007 .

[41]  J. Szaflarski,et al.  Quality of Life in Psychogenic Nonepileptic Seizures , 2003, Epilepsia.

[42]  Jelena Jovanovic,et al.  Anterior cingulate cortex and the Stroop task: neuropsychological evidence for topographic specificity , 2002, Neuropsychologia.

[43]  M. Hotopf,et al.  Frequent attenders with medically unexplained symptoms: service use and costs in secondary care. , 2002, The British journal of psychiatry : the journal of mental science.

[44]  Michael Seid,et al.  PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations , 2001, Medical care.

[45]  J. Varni,et al.  The PedsQL: measurement model for the pediatric quality of life inventory. , 1999, Medical care.

[46]  G. R. Smith,et al.  The course of somatization and its effects on utilization of health care resources. , 1994, Psychosomatics.

[47]  Colin M. Macleod.  Half a century of research on the Stroop effect: an integrative review. , 1991, Psychological bulletin.

[48]  F N Dyer,et al.  The Stroop phenomenon and its use in the stlldy of perceptual, cognitive, and response processes , 1973, Memory & cognition.

[49]  A. Treisman,et al.  The Stroop Test: Selective Attention to Colours and Words , 1969, Nature.

[50]  S. Plioplys,et al.  Pediatric Psychogenic Nonepileptic Seizures: A Concise Review. , 2018, Child and adolescent psychiatric clinics of North America.

[51]  A. Lang,et al.  Psychogenic movement disorders , 2009, Current opinion in neurology.